Geriatric Medicine Market: Current Status, In-depth Analysis and Forecast Outlook 2031

The geriatric medicines market is estimated to grow at a significant CAGR during the forecast period. The primary factor related to the growth of the market is a steep increase in the elderly population across geographical locations, primarily in developed and emerging economies. Besides, the increasing prevalence of chronic disorders, like cancers, diabetes, and rheumatoid arthritis among the geriatrics attributes for the propel of the market. For instance, as per the US data of World Population Prospects for the year 2019, the number of people over the age of 65 raised from 9% in 2019 to more than 16% of the total world's population by 2050. The number of persons aged 80 years or over is also anticipated to triple, from 143 million in 2019 to 426 million in 2050. Therefore, the increase in the volume of the patient pool results in a higher demand for the market boosting the global market growth over the forecast period.

Get Free Sample link @ https://www.omrglobal.com/request-sample/geriatric-medicine-market-share

The analgesics segment is estimated to account for the most remarkable revenue over the forecast period as it is the most common indication with a high happening pain-related syndrome in the elder age. This dominance is due to the occurrence of various reasons, like osteoporosis, lack of musculoskeletal strength, vision impairment, and unintentional falls leading to uncontrollable pain in that age.

Full report of Geriatric Medicine Market available @ https://www.omrglobal.com/industry-reports/geriatric-medicine-market-share

Market Coverage

Segment Covered-
o By Therapeutic Category

o By Condition

Competitive Landscape: Endo Pharmaceuticals Inc., Merck & Co. Inc., AstraZeneca PLC, Pfizer Inc., and Allergan Inc.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominates the market in base year?
Which segment and region will project fastest growth in the market?
How COVID-19 impacted the market?
o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Geriatric Medicine Market by Segment

By Therapeutic Category

• Analgesics

• Antidiabetics

• Antihypertensives

• Antidepressant

• Other Therapeutic Categories

By Condition

• Cardiovascular Diseases (CVDs)

• Diabetes

• Neurological

• Cancer

• Respiratory

• Others (Arthritis and Osteoporosis)

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/geriatric-medicine-market-share

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.